Literature DB >> 28350132

A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.

Wensheng Liu1, Bo Zhang1, Qiangsheng Hu1, Yi Qin1, Wenyan Xu1, Si Shi1, Chen Liang1, Qingcai Meng1, Jinfeng Xiang1, Dingkong Liang1, Shunrong Ji1, Jiang Liu1, Pengfei Hu2, Liang Liu1, Chen Liu1, Jiang Long1, Quanxing Ni1, Xianjun Yu1, Jin Xu1.   

Abstract

N-myc downstream-regulated gene 1 (NDRG1) is known as tumor/metastasis suppressor in a variety of cancers including pancreas, being involved in angiogenesis, cancer growth and metastasis. However, the precise molecular mechanism how NDRG1 exerts its inhibitory function in pancreatic cancer remains unclear. In this investigation, we demonstrated that K-Ras plays a vital role in modulating NDRG1 protein level in PDAC cancer cells in vitro, which is mediated through ERK signaling. Noteworthy, K-Ras downstream Akt/mTOR signaling is inhibited upon NDRG1 overexpression, resulting in decease of HIF1α level. Moreover, NDRG1 has a unique role in modulating cancer metabolism of pancreatic ductal adenocarcinoma (PDAC). The mechanism accounting for NDRG1 in modulating aerobic glycolysis, at least partly, relied on its regulation of glycolysis genes including GLUT1, HK2, LDHA and PDK1. Additionally, NDRG1 is shown to suppress the activity of HIF1α, which is responsible for regulation of glycolysis enzymes. The current study is the first to elucidate a unique facet of the potent tumor/metastasis suppressor NDRG1 in the regulation of PDAC glycolysis, leading to important insights into the mechanism by which NDRG1 exert inhibitory function in PDAC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28350132     DOI: 10.3892/ijo.2017.3938

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

Review 1.  Glycolysis in the progression of pancreatic cancer.

Authors:  Xinyao Chang; Xingchen Liu; Haoze Wang; Xuan Yang; Yan Gu
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

2.  Multifaceted and Intricate Oncogenic Mechanisms of NDRG1 in Head and Neck Cancer Depend on Its C-Terminal 3R-Motif.

Authors:  Guo-Rung You; Joseph T Chang; Hsiao-Fan Li; Ann-Joy Cheng
Journal:  Cells       Date:  2022-05-07       Impact factor: 7.666

3.  Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma.

Authors:  Dingyuan Hu; Daniel Ansari; Krzysztof Pawłowski; Qimin Zhou; Agata Sasor; Charlotte Welinder; Theresa Kristl; Monika Bauden; Melinda Rezeli; Yi Jiang; György Marko-Varga; Roland Andersson
Journal:  Oncotarget       Date:  2018-01-03

Review 4.  Glycolysis and the Hexosamine Biosynthetic Pathway as Novel Targets for Upper and Lower Airway Inflammation.

Authors:  Young Hyo Kim; Tsuguhisa Nakayama; Jayakar Nayak
Journal:  Allergy Asthma Immunol Res       Date:  2018-01       Impact factor: 5.764

5.  ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways.

Authors:  Yehua Shen; Gang Chen; Liping Zhuang; Litao Xu; Junhua Lin; Luming Liu
Journal:  Onco Targets Ther       Date:  2019-06-28       Impact factor: 4.147

6.  Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients.

Authors:  Jun Liu; Zheng Chen; Wenli Li
Journal:  J Oncol       Date:  2021-03-17       Impact factor: 4.375

7.  Glycogen Storage Disease Phenotypes Accompanying the Perturbation of the Methionine Cycle in NDRG3-Deficient Mouse Livers.

Authors:  Hyun Ahm Sohn; Dong Chul Lee; Anna Park; Minho Kang; Byoung-Ha Yoon; Chul-Ho Lee; Yong-Hoon Kim; Kyoung-Jin Oh; Cha Yeon Kim; Seong-Hwan Park; Han Koo; Hyoung-Chin Kim; Won Kee Yoon; Dae-Sik Lim; Daesoo Kim; Kyung Chan Park; Young Il Yeom
Journal:  Cells       Date:  2022-05-04       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.